Back to HomeBeta

ICD-10 Coding for Malignant Tumor of Breast(C50.011, C50.212)

Complete ICD-10-CM coding and documentation guide for Malignant Tumor of Breast. Includes clinical validation requirements, documentation requirements, and coding pitfalls.

Also known as:

Breast CancerBreast CarcinomaMammary Carcinoma

Related ICD-10 Code Ranges

Complete code families applicable to Malignant Tumor of Breast

C50.0-C50.9Primary Range

Malignant neoplasm of breast

This range covers all malignant neoplasms of the breast, specifying location and laterality.

Secondary malignant neoplasm of liver

Used for coding liver metastasis from a primary breast cancer.

Secondary malignant neoplasm of brain

Used for coding brain metastasis from a primary breast cancer.

Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

CodeDescriptionWhen to UseKey Documentation
C50.011Malignant neoplasm of nipple and areola, right female breastUse when the primary site of the breast cancer is the nipple and areola of the right breast.
  • Pathology report confirming invasive carcinoma
  • Documentation of laterality
C50.212Malignant neoplasm of upper-inner quadrant of left female breastUse when the primary site of the breast cancer is the upper-inner quadrant of the left breast.
  • Pathology report confirming invasive carcinoma
  • Documentation of quadrant and laterality

Clinical Decision Support

Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.

Key Information: ICD-10 code for malignant neoplasm of breast

Essential facts and insights about Malignant Tumor of Breast

The ICD-10 code range for malignant neoplasm of the breast is C50.0-C50.9, detailing specific locations and laterality.

Primary ICD-10-CM Codes for malignant tumor of breast

Malignant neoplasm of nipple and areola, right female breast
Billable Code

Decision Criteria

clinical Criteria

  • Confirmed invasive carcinoma of nipple and areola

documentation Criteria

  • Documentation of right breast involvement

Applicable To

  • Invasive carcinoma of nipple and areola

Excludes

  • Benign neoplasm of nipple and areola

Clinical Validation Requirements

  • Pathology report confirming invasive carcinoma
  • Documentation of laterality

Code-Specific Risks

  • Incorrect laterality documentation
  • Missing histological confirmation

Coding Notes

  • Ensure documentation specifies the exact site and laterality.

Ancillary Codes

Additional codes that should be used in conjunction with the main diagnosis codes when applicable.

Estrogen receptor positive status

Z17.0
Use to indicate ER+ status confirmed by immunohistochemistry.

Estrogen receptor negative status

Z17.1
Use to indicate ER- status confirmed by immunohistochemistry.

Differential Codes

Alternative codes to consider when ruling out similar conditions to the primary diagnosis.

Lobular carcinoma in situ of right breast

D05.11
Use D05.11 for non-invasive lobular carcinoma, not invasive.

Malignant neoplasm of lower-inner quadrant of left breast

C50.312
Differentiate based on quadrant location.

Documentation & Coding Risks

Avoid these common documentation and coding issues when documenting Malignant Tumor of Breast to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code C50.011.

Impact

Clinical: Impacts treatment decisions and eligibility for targeted therapies., Regulatory: Non-compliance with documentation standards., Financial: May affect reimbursement for targeted therapies.

Mitigation Strategy

Include receptor status in all pathology reports, Verify documentation completeness before coding

Impact

Reimbursement: May lead to reduced reimbursement rates., Compliance: Non-compliance with coding guidelines., Data Quality: Decreases the quality and specificity of health data.

Mitigation Strategy

Always document and code the specific site and laterality of the tumor.

Impact

Using unspecified codes when specific ones are available.

Mitigation Strategy

Educate providers on the importance of detailed documentation.

Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.

Frequently Asked Questions

Common questions about ICD-10 coding for Malignant Tumor of Breast, with expert answers to help guide accurate code selection and documentation.

Documentation Templates for Malignant Tumor of Breast

Use these documentation templates to ensure complete and accurate documentation for Malignant Tumor of Breast. These templates include all required elements for proper coding and billing.

Documenting invasive ductal carcinoma

Specialty: Oncology

Required Elements

  • Histological type
  • Tumor location
  • Laterality
  • Receptor status

Examples: Poor vs. Good Documentation

Poor Documentation Example
Breast cancer, left side.
Good Documentation Example
Invasive ductal carcinoma, upper-inner quadrant, left breast, ER+, PR+, HER2-.
Explanation
The good example provides specific details about the tumor type, location, and receptor status.

Need help with ICD-10 coding for Malignant Tumor of Breast? Ask your questions below.

Ask about any ICD-10 CM code, or paste a medical note

We build tools for
clinician happiness.

Learn More at Freed.ai
Back to HomeBeta

Built by Freed

Try Freed for free for 7 days.

Learn more